Jerome D. Goldberg

Array ( [id] => 2715793 [patent_doc_number] => 05008287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-04-16 [patent_title] => 'Pharmaceutical compositions having antineoplastic activity' [patent_app_type] => 1 [patent_app_number] => 7/318905 [patent_app_country] => US [patent_app_date] => 1989-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1196 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/008/05008287.pdf [firstpage_image] =>[orig_patent_app_number] => 318905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2587331 [patent_doc_number] => 04963555 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-16 [patent_title] => 'Formulations of heterocyclic compounds' [patent_app_type] => 1 [patent_app_number] => 7/317129 [patent_app_country] => US [patent_app_date] => 1989-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2247 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/963/04963555.pdf [firstpage_image] =>[orig_patent_app_number] => 317129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3413152 [patent_doc_number] => 05444064 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Method of treating gastrointestinal malignancies' [patent_app_type] => 1 [patent_app_number] => 7/317014 [patent_app_country] => US [patent_app_date] => 1989-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 3504 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/444/05444064.pdf [firstpage_image] =>[orig_patent_app_number] => 317014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2687495 [patent_doc_number] => 05049552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-17 [patent_title] => 'Compositions containing hexadecylphosphocholine and use thereof' [patent_app_type] => 1 [patent_app_number] => 7/316413 [patent_app_country] => US [patent_app_date] => 1989-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4280 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/049/05049552.pdf [firstpage_image] =>[orig_patent_app_number] => 316413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2802197 [patent_doc_number] => 05124351 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-23 [patent_title] => 'Pharmaceutical compositions for the treatment of cancers susceptible to treatment with the copper complex of S-(methylthio)-DL-homocysteine or the L-enantimorph thereof' [patent_app_type] => 1 [patent_app_number] => 7/315911 [patent_app_country] => US [patent_app_date] => 1989-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 4832 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/124/05124351.pdf [firstpage_image] =>[orig_patent_app_number] => 315911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2745139 [patent_doc_number] => 05037652 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-08-06 [patent_title] => 'Vancomycin precipitation process' [patent_app_type] => 1 [patent_app_number] => 7/315751 [patent_app_country] => US [patent_app_date] => 1989-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2421 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/037/05037652.pdf [firstpage_image] =>[orig_patent_app_number] => 315751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2603355 [patent_doc_number] => 04948792 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-08-14 [patent_title] => 'Methods for suppressing the endocrine system' [patent_app_type] => 1 [patent_app_number] => 7/310855 [patent_app_country] => US [patent_app_date] => 1989-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 4658 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/948/04948792.pdf [firstpage_image] =>[orig_patent_app_number] => 310855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2621251 [patent_doc_number] => 04950465 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-08-21 [patent_title] => 'Pharmaceutical composition for relieving side effects of platinum-containing drugs' [patent_app_type] => 1 [patent_app_number] => 7/307686 [patent_app_country] => US [patent_app_date] => 1989-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2625 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/950/04950465.pdf [firstpage_image] =>[orig_patent_app_number] => 307686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2633227 [patent_doc_number] => 04952575 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-08-28 [patent_title] => 'Solutions of oxaphosphorins having improved stability and process for the preparation thereof' [patent_app_type] => 1 [patent_app_number] => 7/307230 [patent_app_country] => US [patent_app_date] => 1989-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1910 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/952/04952575.pdf [firstpage_image] =>[orig_patent_app_number] => 307230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2626850 [patent_doc_number] => 04966895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-30 [patent_title] => 'Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents' [patent_app_type] => 1 [patent_app_number] => 7/305234 [patent_app_country] => US [patent_app_date] => 1989-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3985 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/966/04966895.pdf [firstpage_image] =>[orig_patent_app_number] => 305234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2593856 [patent_doc_number] => 04933365 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-06-12 [patent_title] => 'Phospholipase A2 inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/301937 [patent_app_country] => US [patent_app_date] => 1989-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11980 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/933/04933365.pdf [firstpage_image] =>[orig_patent_app_number] => 301937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2766791 [patent_doc_number] => 05006551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-04-09 [patent_title] => 'Composition for destroying malignant tumors' [patent_app_type] => 1 [patent_app_number] => 7/301035 [patent_app_country] => US [patent_app_date] => 1989-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4649 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/006/05006551.pdf [firstpage_image] =>[orig_patent_app_number] => 301035 [rel_patent_id] =>[rel_patent_doc_number] =>)